CYP2D6 genotypes in association with steady state plasma concentrations of active metabolites of tamoxifen in patients with breast cancer.

被引：0
|
作者：
Lim, H.
Lee, H.
Lee, K.
Lee, E.
Jang, I.
Ro, J.
机构：
[1] Natl Canc Ctr, Res Inst & Hosp, Gyeonggi, South Korea
[2] Natl Canc Ctr, Gyeonggi, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36S / 36S
页数：1
相关论文
共 50 条
  • [21] CYP2D6 and tamoxifen: DNA matters in breast cancer
    Hoskins, Janelle M.
    Carey, Lisa A.
    Mcleod, Howard L.
    NATURE REVIEWS CANCER, 2009, 9 (08) : 576 - 586
  • [22] Tamoxifen Resistance and CYP2D6 Copy Numbers in Breast Cancer Patients
    Motamedi, Sahar
    Majidzadeh, Keivan
    Mazaheri, Mahta
    Anbiaie, Robab
    Mortazavizadeh, Seyed Mohammad Reza
    Esmaeili, Rezvan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6101 - 6104
  • [23] Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis
    Jung, Jin-A
    Lim, Hyeong-Seok
    PHARMACOGENOMICS, 2014, 15 (01) : 49 - 60
  • [24] CYP2D6 tamoxifen: Pharmacogenetics in early breast cancer
    Brauch H.
    Schroth W.
    Der Gynäkologe, 2010, 43 (7): : 579 - 585
  • [25] Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
    Chan, Carmen W. H.
    Law, Bernard M. H.
    So, Winnie K. W.
    Chow, Ka Ming
    Waye, Mary M. Y.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (06) : 1395 - 1404
  • [26] Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients
    Fernandez-Santander, Ana
    Gaibar, Maria
    Novillo, Apolonia
    Romero-Lorca, Alicia
    Rubio, Margarita
    Chicharro, Luis Miguel
    Tejerina, Armando
    Bandres, Fernando
    PLOS ONE, 2013, 8 (07):
  • [27] Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment
    Park, Hyung Seok
    Choi, Ji-Yeob
    Lee, Mi-Jeong
    Park, Seho
    Yeo, Chang-Woo
    Lee, Sang Seop
    Shin, Jae-Gook
    Park, Byeong-Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (08) : 1007 - 1013
  • [28] CYP2D6 genotypes in Spanish women with breast cancer
    Ladona, MG
    Abildua, RE
    Ladero, JM
    Roman, JM
    Plaza, MA
    Agundez, JAG
    Munoz, JJ
    Benitez, J
    CANCER LETTERS, 1996, 99 (01) : 23 - 28
  • [29] Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia
    Mihara, K
    Kondo, T
    Yasui-Furukori, N
    Suzuki, A
    Ishida, M
    Ono, S
    Kubota, T
    Iga, T
    Takarada, Y
    de Vries, R
    Kaneko, S
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 287 - 293
  • [30] Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions
    LLerena, A
    Dorado, P
    Berecz, R
    González, AP
    Peñas-LLedó, EM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 59 (12) : 869 - 873
12345